Holen Sie sich die Stockscreener-App
95.83
5.66%
-5.75
Handel nachbörslich:
93.00
-2.83
-2.95%
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
GeneDx Highlights Strong Growth in Earnings Call - TipRanks
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Learn to Evaluate (WGS) using the Charts - Stock Traders Daily
The Goldman Sachs Group Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - Defense World
GeneDx (NASDAQ:WGS) Hits New 52-Week High on Better-Than-Expected Earnings - Armenian Reporter
Allspring Global Investments Holdings LLC Has $7.18 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Corp. SEC 10-K Report - TradingView
A Closer Look at GeneDx Hldgs's Options Market Dynamics - Benzinga
GeneDx Holdings Corp.: A Comprehensive Analysis - HPBL
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - Markets Insider
Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy' - Seeking Alpha
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - Insider Monkey
GeneDx price target raised to $135 from $118 at TD Cowen - TipRanks
3 Stocks On US Exchange Estimated To Be Undervalued By Up To 36.2% - Simply Wall St
GeneDx Holdings Corp (WGS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
GeneDx (NASDAQ:WGS) Hits New 52-Week High After Better-Than-Expected Earnings - Defense World
GeneDx Reports Strong 2024 Growth and 2025 Outlook - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp.WGS - PR Newswire
GeneDx Stock Was up 2,700% in 2024 — Can It Keep Rising? - Investing.com
GeneDx Holdings Corp: A Stock on the Rise - RagingBull
Craig Hallum Raises GeneDx Holdings' Price Target to $114 From $95, Keeps Buy Rating - Marketscreener.com
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday - Benzinga
GeneDx targets $350M-$360M revenue for 2025 with 30% growth in exome and genome testing - MSN
Earnings call transcript: GeneDx Q4 2024 beats forecasts, stock surges - Investing.com
GeneDx Holdings earnings beat by $0.56, revenue topped estimates - Investing.com
GeneDx Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
GeneDx Swings to Adjusted Net Income, Revenue Rises; 2025 Revenue Guidance Set - Marketscreener.com
GeneDx Holdings Corp. Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025 - BioSpace
Genedx Holdings Corp FY 2025 Revenue Guidance Of $350M To $360M -February 18, 2025 at 06:20 am EST - Marketscreener.com
GeneDx Holdings Corp. (NASDAQ:WGS) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? - Benzinga
GeneDx (WGS) Projected to Post Earnings on Tuesday - Defense World
GeneDx (WGS) Expected to Announce Earnings on Tuesday - MarketBeat
GeneDx (NASDAQ:WGS) Shares Up 8%Should You Buy? - MarketBeat
Legato Capital Management LLC Has $2.13 Million Stake in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Reach Out - Markets Insider
GeneDx launches ultrarapid whole genome sequencing for critically ill infants - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect - Markets Insider
GeneDx speeds up genome sequencing for NICU care By Investing.com - Investing.com South Africa
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients - Business Wire
GeneDx (NASDAQ:WGS) Shares Down 6.7%Should You Sell? - MarketBeat
GeneDx to Participate in 45th Annual TD Cowen Health Care Conference - Business Wire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
GeneDx (NASDAQ:WGS) Stock Price Down 6.7%What's Next? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Investors to Inquire about Securities Investigation - Markets Insider
Closing Strong: GeneDx Holdings Corp (WGS) Ends at 59.54, Down -4.23 from Last Close - The Dwinnex
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment - Business Wire
Investors Purchase Large Volume of GeneDx Put Options (NASDAQ:WGS) - MarketBeat
GeneDx (NASDAQ:WGS) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Calamos Advisors LLC Reduces Holdings in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx (NASDAQ:WGS) Sees Large Volume Increase – Here’s What Happened - Armenian Reporter
GeneDx Holdings Corp [NASDAQ: WGS] Sees Decrease in Stock Value - Knox Daily
GeneDX Holdings Stock Q4 2024 Earnings Preview (NASDAQ:WGS) - Seeking Alpha
0.06%
3.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):